DENTSPLY SIRONA Inc. XRAY
9.76 USD +0.06 (+0.62%)
At closeNov 11, 2026, 4:00 PM EST
9.46 -0.30 -3.08%
After hours · Nov 11, 4:00 PM ET
9.37 Day range 9.85
8.14 52-week range 14.76
- YTD
- -14.61%
- 1 year
- -11.11%
News
seekingalpha.com DENTSPLY SIRONA Inc. (XRAY) Q3 2026 Earnings Call Transcript DENTSPLY SIRONA Inc. ( XRAY ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Suzanne Hatcher Daniel Scavilla - President, CEO, Interim Principal Financial Officer & Director…
marketbeat.com DENTSPLY SIRONA Q3 Earnings Call Highlights DENTSPLY SIRONA NASDAQ: XRAY lowered its full-year earnings outlook after third-quarter sales fell across its dental businesses, as pressure from European distributor inventory reductions, the Middle…
zacks.com XRAY Stock Declines as Q3 Earnings & Sales Miss Estimates, Outlook Cut DENTSPLY SIRONA's Q3 sales decline 7.6% amid dental weakness, while Wellspect growth provides support. The company lowers its 2026 outlook.
benzinga.com DraftKings Posts Downbeat Q3 Results, Joins Atlassian, Natera And Other Big Stocks Moving Lower In Friday’s Pre-Market Session Stock futures mixed as DraftKings plunged 21% after earnings missed estimates and FY26 guidance was cut; several other stocks also fell premarket.
zacks.com Dentsply (XRAY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
zacks.com Dentsply International (XRAY) Q3 Earnings and Revenues Miss Estimates Dentsply International (XRAY) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.37 per share a year ago.
benzinga.com Dentsply Sirona Q3 2026 Earnings Call Transcript Dentsply Sirona (NASDAQ:XRAY) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
benzinga.com Dentsply Sirona Lowers FY2026 Adj EPS Guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 Est; Narrows FY2026 Sales Guidance from $3.500B-$3.600B to $3.500B vs $3.570B Est Dentsply Sirona (NASDAQ:XRAY) lowers FY2026 Adj EPS guidance from $1.40-$1.50 to $1.20-$1.30 vs $1.55 analyst estimate. Narrows FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500…
benzinga.com Dentsply Sirona Q3 Adj. EPS $0.29 Misses $0.31 Estimate, Sales $836.000M Miss $862.001M Estimate Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.31 by 6.45 percent. This is a 21.62 percent decrease over earnings of…
globenewswire.com Dentsply Sirona Reports Third Quarter 2026 Results News Summary Q3 2026 net sales of $836 million Q3 2026 GAAP gross margin of 52.9% , GAAP diluted loss per share of ($0.01) Q3 2026 adjusted gross margin of 54.5% , adjusted EBITDA margin of 17.3% ,…
benzinga.com ServiceNow To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday Analysts raised targets for RS, CVLT, SLB, RNG and VEEV; cut targets for XRAY and FUN while maintaining ratings.
benzinga.com Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $13 Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $15 to $13.
benzinga.com Mizuho Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12 Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.- benzinga.com Leerink Partners Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10 Leerink Partners analyst Michael Cherny maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $14 to $10.